Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001235802-12-000063
Filing Date
2012-03-30
Accepted
2012-03-30 17:27:43
Documents
1
Period of Report
2012-03-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 9030
  Complete submission text file 0001235802-12-000063.txt   10498
Mailing Address 112 WEST FEFFERSON BOULEVARD SUITE 613 SOUTH BEND IN 46634
Business Address
MANGANO ROSS J (Reporting) CIK: 0001013724 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31812 | Film No.: 12730519

Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Issuer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)